MT-ND2 / NADH-ubiquinone oxidoreductase chain 2 · Western blot design guide

Design a Western Blot for MT-ND2

Source-linked MT-ND2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MT-ND2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for MT-ND2: expected band ~39 kDa, hero antibody A04475, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable MT-ND2 Western blot protocol sheet — expected band ~39 kDa, antibody A04475, controls and PMC citations. Open the full MT-ND2 WB guide →

MT-ND2 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~39 kDa
Gel 12–15% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat Membrane extraction controls
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Source-Linked MT-ND2 Western Blot Protocol Options

The A04475 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateThe brain of mouse(30ug), The brain of Rat(30ug) (catalog A04475)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA04475; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected MT-ND2 Western Blot Band Size?

MT-ND2 is predicted at 39 kDa; inner-membrane localization may affect recovery, but a migration difference has not been demonstrated.

What am I looking at on my blot?
Band near 39 kDaConsistent with the predicted MT-ND2 mass; confirm its identity with controls
Weak band near 39 kDa in whole-cell lysateLimited recovery of inner-membrane MT-ND2 is possible
No band in whole-cell lysateMitochondrial membrane protein extraction may be insufficient
Stronger band near 39 kDa after mitochondrial enrichmentConsistent with MT-ND2 localization in the mitochondrial inner membrane
💡Expected MT-ND2 appearanceMT-ND2 is predicted to be 39 kDa, with no empirical band size supplied; evaluate a band near that size using mitochondrial enrichment and band-identity controls.
How each factor affects band size
UniProt predicted massProvides a 39 kDa reference for full-length MT-ND2
Calculated molecular weight38,961 Da rounds to approximately 39 kDa
Predicted full-length sizeDoes not establish the apparent band position on a blot
Sequence-based mass estimateProvides no evidence for a distinct shifted band
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatePoor recovery of mitochondrial inner-membrane MT-ND2Check mitochondrial enrichment and membrane protein extraction
Band higher than expectedBand identity or apparent migration is uncertainCompare mitochondrial-enriched and control samples
Band lower than expectedPossible degradation or unrelated antibody signalCheck sample integrity and band-identity controls
Multiple bandsNo supplied MT-ND2 feature establishes multiple band sizesCompare bands across mitochondrial-enriched and control samples
Weak or no signalInefficient recovery of a multi-pass inner-membrane proteinAssess membrane extraction and sample loading

Sample controls for MT-ND2 Western blot

🧪For positive controls for MT-ND2 in Western blot, you can use a sample containing mitochondrial inner membranes, but the supplied HPA data identify no positive tissue or cell line.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: HPA provides no tissue-expression data, so a positive tissue and a clean negative tissue cannot be established from this evidence.

HPA tissue expression evidence for MT-ND2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced MT-ND2 Western Blot Tips

Deeper troubleshooting and optimisation questions for MT-ND2, answered from its protein features.

How should MT-ND2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could an MT-ND2 isoform explain a second band?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no isoform-based explanation for a second band. Check band specificity before assigning either band to MT-ND2.
Could annotated modifications explain an MT-ND2 band shift?
PTM · The supplied features list no modified residues or glycosylation sites, and no signal peptide or propeptide. They provide no annotated modification or processing event to assign to a shifted band. They also cannot rule out an unlisted cause.
Does this guide establish induction of MT-ND2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for MT-ND2 Western blot?
Transfer · MT-ND2 is a predicted 39-kDa, multi-pass mitochondrial inner-membrane protein. Select transfer conditions appropriate for that size and verify transfer by checking both the membrane and post-transfer gel. The supplied features do not identify one optimal transfer method.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A04475 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should MT-ND2 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Should MT-ND2 run exactly at its predicted 39 kDa?
Interpretation · The supplied predicted mass is 39 kDa, but no observed band position is available. Use 39 kDa as a reference, not an expected exact migration position. The listed features alone cannot establish a visible shift or explain a difference between apparent and predicted mass.

MT-ND2 is a mitochondrial inner-membrane subunit of Complex I. Compare samples using consistent mitochondrial preparation and protein loading, and quantify the same validated band in each lane. A change in MT-ND2 signal alone does not establish a change in the entire 45-subunit complex.

First assess band specificity and sample preparation. The supplied record predicts 39 kDa, lists one isoform, and provides no modified residues, glycosylation sites, signal peptide, or propeptide. Those features do not assign an identity to an unexpected band or establish why it migrates differently.
Boster reagents

MT-ND2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot (WB) analysis of MT-ND2 polyclonal antibody at 1:1000 dilution Lane1:The brain tissue lysate of mouse(30ug) Lane2:The brain tissue lysate of Rat(30ug)
Anti-MT-ND2 Antibody
Cat # A04475

A04475 is an anti-MT-ND2 polyclonal antibody listed for human, mouse, and rat. Its WB image shows mouse and rat brain tissue lysates (30 µg per lane) at 1:1000 dilution; the supplied image does not show a human sample.

Which to pick: A04475 is the only listed option. Its WB image provides a starting reference for mouse or rat brain lysate; human reactivity is listed, but no human WB sample is shown.

Source: BosterBio MT-ND2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.